Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2006
10/05/2006US20060222654 Methods and compounds for raising antibodies and for screening antibody repertoires
10/05/2006US20060222653 Antibodies operably linked to selected chemoattractants
10/05/2006US20060222652 Molecular antigen array
10/05/2006US20060222651 Staphylococcal immunotherapeutics via donor selection and donor stimulation
10/05/2006US20060222650 Broad spectrum pyrogenic antagonists and vaccines directed against pyrogenic exotoxins
10/05/2006US20060222649 Methods for inducing antigen-specific T cell tolerance
10/05/2006US20060222648 Graft-versus-host disease; inhibit secretion of Interferon-gamma (IFN-?) by lymphocytes or other immune cells in a mammal; inflammatory bowel disease is Crohn's disease, ulcerative colitis, or ileitis; KIM-1 (Kidney Injury Molecule-1)
10/05/2006US20060222647 Methods and compositions for modulating the activity of PDE5
10/05/2006US20060222646 Anti-TNFalpha antibodies in therapy of asthma
10/05/2006US20060222645 Specifically bind to and neutralize angiopoietin-like protein 4 (ANGPTL4); disorder of lipid metabolism
10/05/2006US20060222644 Humanized anti-Lymphotoxin beta receptor antibodies
10/05/2006US20060222643 Anti-mpl antibody
10/05/2006US20060222642 Compositions for the treatment of mycobacterial infections
10/05/2006US20060222633 Prevention, decrease, and/or treatment of immunoreactivity by depleting and/or inactivating antigen presenting cells in the host
10/05/2006US20060222629 Compositions and methods for delivery of genetic material
10/05/2006US20060222624 Detoxified TNF and method of preparing
10/05/2006US20060222597 Buccal, polar and non-polar sprays containing propofol
10/05/2006US20060222595 Nanoparticles for therapeutic and diagnostic applications
10/05/2006US20060222588 Antilymphoma targeting agents with effector and affinity functions linked by a trifunctional reagent
10/05/2006DE19744127B4 Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with Cyclopropylringen in the side chains, processes and intermediates for their preparation and their use for the production of pharmaceuticals
10/05/2006DE102005013846A1 Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie Identifying surface-associated antigens for tumor diagnosis and therapy
10/05/2006CA2634038A1 Liposome composition for immune induction
10/05/2006CA2603356A1 Methods and means for diagnostics, prevention and treatment of mycobacterium infections and tuberculosis disease
10/05/2006CA2603298A1 Tuberculosis vaccine and method for making same
10/05/2006CA2603052A1 Immunogenic egfr peptides comprising foreign t cell stimulating epitope
10/05/2006CA2602777A1 Gitr binding molecules and uses therefor
10/05/2006CA2602637A1 Vaccines against chlamydial infection
10/05/2006CA2602122A1 A method of diagnosis and treatment and agents useful for same
10/05/2006CA2599988A1 Methods and compositions for modulating hyperstabilized c-met
10/05/2006CA2598884A1 Influenza nucleic acids, polypeptides, and uses thereof
10/04/2006EP1707633A1 Alphavirus vectors for paramyxovirus vaccines
10/04/2006EP1707627A1 Mutants of anti-cd40 antibody
10/04/2006EP1707215A1 Remedy for angitis
10/04/2006EP1707214A1 Antagonists of HMG1 for treating inflammatory conditions and the use of HMG1 for effecting weightloss or treating obesity
10/04/2006EP1706499A2 Human cytomegalovirus us3 gene promoter
10/04/2006EP1706486A1 Chimeric empty capsids of the infectious bursal disease virus (ibdv), obtainment process and applications
10/04/2006EP1706485A1 EMPTY CAPSIDS (VLPs(-VP4)) OF THE INFECTIOUS BURSAL DISEASE VIRUS (IBDV), OBTAINMENT PROCESS AND APPLICATIONS
10/04/2006EP1706481A2 Vaccine
10/04/2006EP1706428A2 Anti-cancer antibodies with reduced complement fixation
10/04/2006EP1706427A2 Human binding molecule against cd1a
10/04/2006EP1706425A2 Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse®
10/04/2006EP1706424A1 Fc region variants
10/04/2006EP1706423A2 Therapeutic and diagnostic anti-hsp 70 antibodies
10/04/2006EP1706421A2 Methods of modulating cytokine activity; related reagents
10/04/2006EP1706418A2 Live genetically attenuated malaria vaccine
10/04/2006EP1706152A2 Particle-induced ghrelin immune response
10/04/2006EP1706145A1 Autoantibodies utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment
10/04/2006EP1706144A2 Medicament comprising inhibitors of long pentraxin ptx3
10/04/2006EP1706143A1 Cd40 antibody formulation and methods
10/04/2006EP1706142A1 Streptococcus phocae vaccine
10/04/2006EP1706141A1 Methods of using botulinum toxin for the treatment of hypervolemic lip deformity (lip ectropion)
10/04/2006EP1706140A1 Methods for tailoring the immune response to an antigen or immunogen
10/04/2006EP1706079A2 Antibodies against factor viii with modified glycosylation in the variable region
10/04/2006EP1705992A1 Intratumoral delivery of dendritic cells
10/04/2006EP1311691B1 Method and compositions for promoting osteogenesis
10/04/2006EP1162996B1 Hapten-conjugated mammalian cells and methods of making and using thereof
10/04/2006EP1161537B1 Non-spreading pestivirus
10/04/2006EP1143931B1 Pulmonary drug delivery
10/04/2006EP1109918B1 Mitogen- and stress-activated protein kinases that contain two kinase domains and uses thereof
10/04/2006EP1082435B1 Proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
10/04/2006EP1027375B1 Anti-idiotypic monoclonal antibodies, their use in the active immunotherapy of malignant tumors, and compositions containing them
10/04/2006EP1003861B1 Mammalian cell membrane proteins; related reagents
10/04/2006EP0957936B1 Formulations of recombinant papillomavirus vaccines
10/04/2006EP0783525B1 Humanized antibodies against respiratory syncytial virus
10/04/2006EP0689601B1 Production of high titer helper-free retroviruses by transient transfection
10/04/2006CN1842603A Method of selecting wt1 vaccine adaptive patient
10/04/2006CN1842602A Modified vaccinia virus ankara (MVA) mutant and use thereof
10/04/2006CN1842540A Anti-glypican 3 antibody
10/04/2006CN1842346A Regulation of the cytotoxic lymphocyte response by macrophage migration inhibitory factor
10/04/2006CN1842345A Oral solid dose vaccine
10/04/2006CN1841066A Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
10/04/2006CN1840665A Virulence genes, proteins, and their use
10/04/2006CN1840541A Helicobacter pylori protein and its preparing method and use
10/04/2006CN1840204A Lentiviral vectors for the preparation of immunotherapeutical compositions
10/04/2006CN1840192A Immunity regulator and its application
10/04/2006CN1840191A Immunity regulator and its application
10/04/2006CN1840190A Medicine composition for treating allergic disease and method for preparing the same
10/04/2006CN1840189A Mixture with dust mite for treating allergy
10/04/2006CN1840188A A recombined smallpox vaccine - SARS vaccine and preparation method thereof
10/04/2006CN1839788A Immune globulin G biological factor oral detergent
10/04/2006CN1277582C Method for removing endotoxin from influenza vaccine formulation
10/03/2006US7115731 Vectors; cells; drug targets
10/03/2006US7115729 Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53
10/03/2006US7115725 Polypeptide for use in the generation of vaccine against diphtheria toxin
10/03/2006US7115723 Humanized antibody specific for surface antigen pre-S1 of HBV and preparation method thereof
10/03/2006US7115717 Immunoglobulin specific to tumor necrosis factor -related apoptosis-inducing ligand (TRAIL) for use in the prevention and treatment of cancer; immnotherapy
10/03/2006US7115715 Oncogenic protein for use in the diagnosis and treatment of tumors
10/03/2006US7115713 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
10/03/2006US7115707 Amino acid sequences capable of facilitating penetration across a biological barrier
10/03/2006US7115663 Increased or improved bioavailability of the active agent
10/03/2006US7115582 Useful in localized transfer of genetic material or proteins. Moreover, the present invention provides methods and compositions for improving and/or controlling wound healing by applying a wound care device comprising HoxD3 and/or HoxA3
10/03/2006US7115581 Autoimmune disease therapy; injections
10/03/2006US7115554 Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III
10/03/2006US7115414 Comprises nucleotide sequences coding transmembrane protein/transport protein (TRPV3) for treating pain, inflammation and skin disorders
10/03/2006US7115405 Recombinantly produced, enzymatically active, includes two amino acid motifs
10/03/2006US7115392 Polynucleotides encoding human vascular endothelial growth factor 2
10/03/2006US7115391 Production of recombinant AAV using adenovirus comprising AAV rep/cap genes
10/03/2006US7115379 A complex of an antibody or antigen-binding fragment and a polypeptide which chemoattracts peripheral blood monocytes or T-cells
10/03/2006US7115363 Retrovirus capable of causing AIDS, means and methods for detecting it in vitro
10/03/2006US7115361 Detection of CD8+ T cell responses to M. tuberculosis